Long-term functional benefits of human embryonic stem cell-derived cardiac progenitors embedded into a fibrin scaffold

J Heart Lung Transplant. 2015 Sep;34(9):1198-207. doi: 10.1016/j.healun.2014.10.008. Epub 2014 Nov 7.

Abstract

Background: Cardiac-committed cells and biomimetic scaffolds independently improve the therapeutic efficacy of stem cells. In this study we tested the long-term effects of their combination.

Methods: Eighty immune-deficient rats underwent permanent coronary artery ligation. Five to 7 weeks later, those with an echocardiographically measured ejection fraction (EF) ≤55% were re-operated on and randomly allocated to receive a cell-free fibrin patch (n = 25), a fibrin patch loaded with 700,000 human embryonic stem cells (ESC) pre-treated to promote early cardiac differentiation (SSEA-1(+) progenitors [n = 30]), or to serve as sham-operated animals (n = 25). Left ventricular function was assessed by echocardiography at baseline and every month thereafter until 4 months. Hearts were then processed for assessment of fibrosis and angiogenesis and a 5-component heart failure score was constructed by integrating the absolute change in left ventricular end-systolic volume (LVESV) between 4 months and baseline, and the quantitative polymerase chain reaction (qPCR)-based expression of natriuretic peptides A and B, myosin heavy chain 7 and periostin. All data were recorded and analyzed in a blinded manner.

Results: The cell-treated group consistently yielded better functional outcomes than the sham-operated group (p = 0.002 for EF; p = 0.01 for LVESV). Angiogenesis in the border zone was also significantly greater in the cell-fibrin group (p = 0.006), which yielded the lowest heart failure score (p = 0.04 vs sham). Engrafted progenitors were only detected shortly after transplantation; no grafted cells were identified after 4 months. There was no teratoma identified.

Conclusions: A fibrin scaffold loaded with ESC-derived cardiac progenitors resulted in sustained improvement in contractility and attenuation of remodeling without sustained donor cell engraftment. A paracrine effect, possibly on innate reparative responses, is a possible mechanism for this enduring effect.

Keywords: cardiac patches; cardiac progenitors; cell transplantation; embryonic stem cells; heart failure; stem cells; tissue engineering.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inducing Agents
  • Animals
  • Cell Adhesion Molecules / analysis
  • Coronary Vessels
  • Echocardiography
  • Embryonic Stem Cells*
  • Female
  • Fibrin*
  • Heart Failure
  • Humans
  • Immunohistochemistry
  • Ligation
  • Mice, Nude
  • Myocardium / cytology*
  • Myosin Heavy Chains
  • Natriuretic Peptides / analysis
  • Polymerase Chain Reaction
  • Rats
  • Stem Cells*
  • Stroke Volume
  • Tissue Scaffolds*
  • Ventricular Function, Left

Substances

  • Angiogenesis Inducing Agents
  • Cell Adhesion Molecules
  • Natriuretic Peptides
  • Postn protein, rat
  • Fibrin
  • Myosin Heavy Chains